HARBIN, China, Oct. 13, 2011 /PRNewswire-Asia-FirstCall/ --
China Sky One Medical, Inc. ("China Sky One Medical" or "the
Company") (NASDAQ: CSKI), a leading fully integrated pharmaceutical
company producing over-the-counter drugs in the People's Republic of China ("PRC"), today
announced that it held its 2011 Annual Meeting of Stockholders (the
''Annual Meeting'') on October 12,
2011, in Harbin, PRC.
At the Annual Meeting, the Company's stockholders were asked to
vote on a proposal to elect seven directors to serve until the
Company's 2012 Annual Meeting of Stockholders, or until such time
as their respective successors are elected and qualified. The
stockholders elected Mr. Yan-qing Liu, Mr. Chun-fang Song, Ms.
Xu-feng Qian, Mr. Jie Zhao, Mr.
William Wei Lee, Mr. Wen-chao Zhang
and Mr. Jian-ping Li as members of the Board of Directors of the
Company by a plurality of the votes cast.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company. The
Company primarily engages in the manufacturing, marketing and
distribution of over-the-counter pharmaceutical, medicinal and
diagnostic products. Through its wholly-owned subsidiaries, Harbin
Tian Di Ren Medical Science and Technology Company, Harbin First
Bio-Engineering Company Limited, Heilongjiang Tianlong
Pharmaceutical, Inc. and Peng Lai Jin Chuang Pharmaceutical
Company, the Company manufactures and distributes primarily to and
through domestic pharmaceutical chains in China. For more information, visit
http://www.cski.com.cn.
Investor
Relations Contact:
|
|
|
|
|
|
China Sky
One
Medical
|
CCG Investor
Relations
|
|
Hongyu Pan, CFO
|
David Rudnick
|
|
Email: ir@cski.com.cn
|
Tel:
+1-646-626-4172
|
|
|
Email:
david.rudnick@ccgir.com
|
|
|
Website:
www.ccgirasia.com
|
|
|
|
|
|
Mabel Zhang, Vice
President
|
|
|
Tel:
+1-310-954-1353
|
|
|
Email: mabel.zhang@ccgir.com
|
|
|
|
SOURCE China Sky One Medical, Inc.